Swapan Khandelwal Acquires 78,000 Shares in Goldline Pharmaceutical

Swapan Khandelwal, Promoter and Whole Time Director of Goldline Pharmaceutical Limited, has acquired 78,000 equity shares through an open market purchase. This acquisition increases his total shareholding to 2,887,988 shares, representing 30.08% of the company's total paid-up share capital. The transaction occurred on August 28, 2026, and the total equity share capital of the company remains at 9,600,000 shares.